Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Robert J Palmisano is Director at Aeon Biopharma. OQRO lists 2 transactions filed with the SEC under this name, the latest on Jun 22, 2026, each linked to the official Form 4.
Director
Disclosures on record
2
Companies involved
2
As of the latest filing on , Robert J Palmisano reported holding 78,076 shares of Rxsight (RXST), worth about $415K at the last close of $5 (Nov 13, 2026). Holdings are also on file at Aeon Biopharma (AEON); together they are worth about $455K.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Rxsight RXST | 78,076 | 78K direct | $5 | $415K | Jun 17, 2026 |
| Aeon Biopharma AEON | 258,705 | 259K direct | $0 | $40K | Jun 17, 2026 |
Is this Robert J Palmisano’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Aeon BiopharmaAEON
Jun 17, 2026223Kdisclosed Jun 22
DetailsOfficial recordRxsightRXST
Jun 17, 202637Kdisclosed Jun 18
DetailsOfficial recordOn the latest SEC Form 4, dated Jun 17, 2026, Robert J Palmisano reported holding 78,076 shares of Rxsight (RXST). At the last close of $5 on Nov 13, 2026, that is about $415K. This is the stake disclosed in filings, not a net worth.
